Alliance Pharma plc (APH) — Long-term Investment Intensity
Alliance Pharma plc (APH) has a Long-term Investment Intensity of 0.4% as of December 2017. Long-term investments of GBX1.48 Million represent 0.4% of total assets of GBX336.48 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Alliance Pharma plc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Alliance Pharma plc Long-term Investment Intensity (2013–2017)
This chart shows how Alliance Pharma plc's Long-term Investment Intensity has evolved across 5 annual periods from 2013 to 2017. As of December 2017, the intensity stands at 0.4%, reflecting long-term investments of GBX1.48 Million against total assets of GBX336.48 Million GBX. Also explore APH total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Alliance Pharma plc (2013–2017)
The table below presents the year-by-year Long-term Investment Intensity for Alliance Pharma plc from 2013 to 2017, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see APH market cap.
| Year | LT Investment Intensity | LT Investments (GBX) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 0.4% | GBX1.48 Million | GBX336.48 Million | ▼ 0.0 pp |
| 2016 | 0.5% | GBX1.46 Million | GBX320.74 Million | ▼ 0.0 pp |
| 2015 | 0.5% | GBX1.47 Million | GBX292.19 Million | ▼ -0.7 pp |
| 2014 | 1.2% | GBX1.27 Million | GBX107.87 Million | ▲ +0.3 pp |
| 2013 | 0.9% | GBX976.00K | GBX106.99 Million | — |